Jirapat Wonglhow

prince of songkla university

H指数:3

被引数:43

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Determination of Exploratory Metastasis Biomarkers in Cancer of Unknown Primary Using Metastatic Colon Cancer as a Model: RNA Sequencing Bioinformatics Analysis

利用转移性结肠癌作为模型确定未知原发灶癌症的探索性转移生物标志物：RNA测序生物信息学分析

Current Issues in Molecular Biology

IF3

2026-10-150

Clinical Prognostic Factors and Survival Risk Stratification for Advanced Biliary Tract Cancer Treated with Gemcitabine-Based Palliative Chemotherapy: A Real-World Retrospective Study

临床预后因素及接受吉西他滨为基础的姑息化疗的晚期胆道癌患者的生存风险分层：一项真实世界回顾性研究

Life-Basel

IF3.4

2026-08-240

Choosing the Platinum Partner in Advanced Biliary Tract Cancer: A Propensity Score–Matched Real-World Comparison of Gemcitabine Plus Carboplatin Versus Gemcitabine Plus Cisplatin

在先进胆道癌中选择铂类伴侣药物：吉西他滨联合卡铂与吉西他滨联合顺铂的倾向性评分匹配真实世界比较

Life-Basel

IF3.4

2026-07-270

OAAI

Survival Outcomes and Prognostic Factors in Metastatic Unresectable Appendiceal Adenocarcinoma Treated with Palliative Systemic Chemotherapy: A 10-Year Retrospective Analysis from Australia

转移性不可切除阑尾腺癌患者接受姑息性全身化疗的生存结局及预后因素：一项来自澳大利亚的10年回顾性分析

Cancers

IF4.4

2026-03-030

OAAI

Trends in Cancer Diagnoses Among People Living with HIV: A 20-Year Retrospective Study from a Tertiary Center in Thailand

艾滋病病毒感染者癌症诊断趋势：来自泰国一家三级中心的一项20年回顾性研究

Journal of Clinical Medicine 2026, Vol. 15, Page 22

IF2.9

2025-12-200

OAAI

Effectiveness of Palliative Chemotherapy and Associated Prognostic Factors in Advanced Small Bowel Adenocarcinoma: A Propensity Score-Matched Analysis

姑息性化疗在晚期小肠腺癌中的有效性及相关的预后因素：一项倾向性评分匹配分析

Cancer Management and Research

IF2.6

2025-11-250

OAAI

Effectiveness of Chemotherapy Plus Immunotherapy and Molecular Alterations in Advanced Biliary Tract Cancer: Real-World Evidence From a Single-Center Australian Cohort

Cancer Control

IF0

2025-11-010

PRE

Role of Adjuvant Chemotherapy in Resected Small Bowel Adenocarcinoma: An Exploratory Real-World Analysis of Survival Outcomes and Prognostic Factors

辅助化疗在切除后的小肠腺癌中的作用：一项探索性真实世界分析，研究生存结局和预后因素

Journal of Clinical Medicine 2025, Vol. 14, Page 7513

IF0

2025-10-230

OAAI

A 20-Year Real-World Study of Small Bowel Cancers: Histologic Subtypes, Clinical Features, and Survival Implications

一项为期20年的小肠癌真实世界研究：组织学亚型、临床特征及生存意义

Journal of Clinical Medicine 2025, Vol. 14, Page 6962

IF2.9

2025-10-010

OAAI

Real-World Outcomes Between Perioperative Chemotherapy (FLOT) and Preoperative Concurrent Chemoradiotherapy (CROSS) in Localized Esophageal and Esophagogastric Junction Adenocarcinoma: A Retrospective Cohort Study

局部食管和食管胃结合部腺癌中围手术期化疗（FLOT）与术前同期化放疗（CROSS）的真实世界结局比较：一项回顾性队列研究

Cancers 2025, Vol. 17, Page 2962

IF0

2025-09-100

OAAI

Real-World Systemic Treatment Patterns, Survival Outcomes, and Prognostic Factors in Advanced Hepatocellular Carcinoma: A 15-Year Experience from a Low-Resource Setting

真实世界系统性治疗模式、生存结局及预后因素在晚期肝细胞癌中的研究：一项来自低资源环境15年的经验

Cancers 2025, Vol. 17, Page 2729

IF4.4

2025-08-220

PRE

Association Between Epstein-Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications

EB病毒感染与胃癌PD-L1表达的关系：患病率、临床病理特征及预后意义

CANCERS

IF4.4

2025-04-290

Comparative Analysis of Concurrent Chemoradiotherapy Versus Chemotherapy Alone as First-Line Palliative Treatments for Advanced Esophageal Squamous Cell Carcinoma

同期放化疗与单纯化疗一线姑息治疗晚期食管鳞癌的对比分析

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-10-230

OAAI

The Performance of a Survival Nomogram and Albumin-Bilirubin Grade as Prognostic Tools in Advanced Hepatocellular Carcinoma Treated with FOLFOX4

JOURNAL OF PERSONALIZED MEDICINE

IF3

2024-04-111

Comparing the Efficacy of Carboplatin plus 5-Fluorouracil, Cisplatin plus 5-Fluorouracil, and Best Supportive Care for Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Analysis from a Tertiary Hospital in Southern Thailand

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-03-171

OAAI

LABS score- a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study

BMC CANCER

IF3.4

2024-03-010

OAAI

LABS score: The prognostic tool for advanced hepatocellular carcinoma treated with FOLFOX4 and real-world efficacy from a single-center retrospective study

ANNALS OF ONCOLOGY

IF65.4

2022-11-010

OAAI

LONG-TERM RE-BLEEDING AND ITS PREDICTORS AFTER CAPSULE ENDOSCOPY IN PATIENTS WITH OBSCURE GASTROINTESTINAL BLEEDING

GASTROINTESTINAL ENDOSCOPY

IF7.5

2019-06-010

PREAI

Jirapat Wonglhow

个人简介

教育背景

工作经历

荣誉奖项

研究方向